or 4 fortnightly payments of $19.99 with More info
8 in stock
Topical fat-loss is an area that has been significantly under explored in the supplement industry. We all know Yohimbine works, however when taken orally the effect can be quite uncomfortable in the stomach – just a little too much and you can feel like you will never take it again! Caspsaicin is very similar, it works! But take a big oral dose and your bound to feel like you just participated in a Mexican chilli eating contest. Thats where topical application not only bypasses the stomach but also delivers these ingredients to precisely the location on the body you want to target. Take a look at what the creators of this product have to say below:
MPA VasoBurn is a topical skin gel that glides on smoothly, and dries rapidly. The ingredients in MPA VasoBurn may support the appearance of tighte , firmer, and thinner skin texture for an overall leaner appearance
IDEAL FOR USE IN COMBINATION WITH/DURING YOUR CALORIC DEPRIVATION PERIODS.
CLEAN GEL APPLICATION
The best places to apply MPA VasoBurn are — abdominals, glutes, inner thighs, chest, and of course … the lower back (love handle area).
Apply MPA VasoBurn after showering — washing away dead skin cells from the body — ensuring maximum coverage.
A finely trimmed or shaved body may also enhance the effect of ingredients by negating the occurrence of body hair that can make application difficult.
Test a small portion on your forearm. After testing on forearm, remember to use a dime size amount on each area.
When applying after a hot shower, and especially after shaving if you have sensitive skin.
Water (Aqua/Eua), Ethyl Alcohol (organic), Dimethyl Isosorbide, Ethoxydiglycol, 3-Aminopropanoic Acid, Yohimbine Hydrochloride, Triethanolamine, Theophylline, Zingiber Officinale (Ginger) Root Extract, Carbomer, Raspberry Ketone, Benzyl Nicotinate, Trans-Cinnamaldehyde oil, Tetrahydropiperine*, N-Vanillylnonanamide.
1.) C Morimoto, et al. Life Sci, May 27, 2005; 77(2): 194-204
2.) Frank et al. Obes Res. 1995;3 (Suppl 4): 561S-568S
3.) Caruso MK, et al Diabetes Obes Metab. 2007 May;9(3):300-3.
4.) Zhao X, et al. Int J Pharm. 2006 Dec 11;327(1-2):58-64. Epub 2006 Jul 21.
5.) GD Lundberg Medscape J Med, Jan 2008; 10(2): 43.
6.) Kobayashi,Y. et al. Planta Med., 67, 628–633.(2001)
7.) P Arner, et al.J. Lipid Res., Oct 1993; 34: 1737.
Results may vary from person to person
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
We make no ‘therapeutic claims’. Therapeutic goods are broadly defined by the TGA as products for use in humans in connection with:
• preventing,diagnosing, curing or alleviating a disease, ailment, defect or injury
• influencing inhibiting or modifying a physiological process
• testing the susceptibility of persons to a disease or ailment
• influencing, controlling or preventing conception
• testing for pregnancy
|Dimensions||5 × 5 × 15 cm|
or 4 payments of $22.49 with AfterpayAdd to cart
or 4 payments of $7.49 with AfterpayAdd to cart